D DENALI THERAPEUTICS INC
| Market Cap | $3.27B |
| P/E Ratio | — |
| Forward P/E | -8.46 |
| Dividend Yield | — |
| Beta | 1.10 |
| 52W Range | $11.47 - $22.74 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $444.00K | 26,900 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 4 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Schuth Alexander O.COFO and Secretary | Sale | 17,218 | $16.50 | $284.10K | 06 Jan 2026 | 08 Jan 2026 |
| Watts Ryan J.President and CEO | Sale | 35,198 | $16.50 | $580.77K | 06 Jan 2026 | 08 Jan 2026 |
| BAKER BROS. ADVISORS LP | Buy | 190,523 | $17.49 | $3.33M | 11 Dec 2025 | 15 Dec 2025 |
| BAKER BROS. ADVISORS LP | Buy | 2,095,191 | $17.49 | $36.64M | 11 Dec 2025 | 15 Dec 2025 |
Frequently Asked Questions
What is DNLI stock price today?
DENALI THERAPEUTICS INC (DNLI) is currently trading at $20.65. The stock has a 52-week range of $11.47 to $22.74 and a market capitalization of $3.27B.
Is DNLI a good stock to buy in 2026?
DENALI THERAPEUTICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +61.5%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling DNLI stock?
There have been 4 insider transactions for DNLI in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has DNLI stock performed over the past year?
DENALI THERAPEUTICS INC (DNLI) has returned +61.5% over the past 12 months. The stock traded between $11.47 and $22.74 during this period, and is currently at $20.65.
Which hedge funds own DNLI (DENALI THERAPEUTICS INC)?
1 tracked hedge funds currently hold DNLI in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is DNLI's market cap and valuation?
DENALI THERAPEUTICS INC (DNLI) has a market capitalization of $3.27B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is DNLI's revenue and profitability?
DENALI THERAPEUTICS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 1.10.
What sector is DNLI in and who are its biggest institutional holders?
DENALI THERAPEUTICS INC (DNLI) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.